Cargando…
The Current State of Clinical Application of Serum Biomarkers for Canine Lymphoma
Serum biomarkers of canine lymphoma activity for diagnosis, prognosis, and therapy monitoring have been of clinical interest for more than a decade. Tumor products, biochemical enzymes, cytokines, metabolic profiling, leakage enzymes, as well as serum proteins have been studied as biomarkers for lym...
Autor principal: | Bryan, Jeffrey N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042957/ https://www.ncbi.nlm.nih.gov/pubmed/27747218 http://dx.doi.org/10.3389/fvets.2016.00087 |
Ejemplares similares
-
Editorial: Canine Intervertebral Disc Disease: The Current State of Knowledge
por: Olby, Natasha J., et al.
Publicado: (2021) -
Canine chronic enteropathy—Current state-of-the-art and emerging concepts
por: Jergens, Albert E., et al.
Publicado: (2022) -
Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma
por: Aresu, Luca, et al.
Publicado: (2021) -
A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma
por: Sharif, Hanan, et al.
Publicado: (2023) -
Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma
por: Dias, Joana N. R., et al.
Publicado: (2021)